This inventor holds 28 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent, primarily in Antiviral Compounds. Top assignees: Biochem Pharma Inc., Shire Biochem, Inc., Vertex Pharmaceuticals (Canada) Incorporated. Active years: 1991-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brossard, CA (1991 - 1993)
- Quebec, CA (1996 - 2003)
- La Praire, CA (2006)
- La Prairie, CA (1991 - 2014)
Company Filing History:
18 out of 62 
3 out of 16 
3 out of 6 Years Active: 1991-2014
Areas of Expertise:
Title: Nghe Nguyen-Ba: Pioneering Innovator in Flavivirus Treatment and Prevention
Introduction:
Nghe Nguyen-Ba, a highly accomplished inventor and researcher from La Prairie, CA, has established himself as a prominent figure in the field of pharmaceutical innovations. With an impressive portfolio of 28 patents, Nghe Nguyen-Ba has made significant contributions to the treatment and prevention of Flaviviridae viral infections. In this article, we will delve into his latest patents, career highlights, notable collaborations, and conclude with an appreciation of his invaluable contributions to the medical field.
Latest Patents:
Nghe Nguyen-Ba's recent patents focus on novel compounds and methods for treating or preventing Flaviviridae viral infections. The patents describe compounds represented by a specific chemical formula, along with their pharmaceutically acceptable salts and related compounds. These inventions offer promising possibilities for combating and managing Flaviviridae infections in hosts. The utilization of such innovative compounds in the treatment and prevention of viral infections underscores Nghe Nguyen-Ba's visionary approach to pharmaceutical advancements.
Career Highlights:
Throughout his prolific career, Nghe Nguyen-Ba has worked with esteemed companies, contributing immensely to the healthcare industry. Notably, he has been associated with Biochem Pharma Inc. and Shire Biochem, Inc., both renowned entities in the pharmaceutical arena. As a valued member of these organizations, Nghe Nguyen-Ba has played a pivotal role in driving scientific research and development, striving for breakthrough innovations that can make a positive impact on public health.
Collaborations:
Nghe Nguyen-Ba's expertise and dedication have led to collaborations with exceptional industry professionals. Among his notable coworkers, Bernard R. Belleau and Laval Chan Chun Kong have been instrumental in fostering a collaborative environment for cutting-edge research. These partnerships have facilitated the exchange of ideas, pooling of resources, and interdisciplinary approaches, ultimately enhancing the potential for revolutionary discoveries in the field.
Conclusion:
Nghe Nguyen-Ba's unwavering commitment to advancing the treatment and prevention of Flaviviridae viral infections has solidified his standing as an exceptional innovator. With an extensive patent portfolio and a remarkable career spanning prestigious organizations, Nghe Nguyen-Ba continues to shape the pharmaceutical landscape. Through collaborations with esteemed colleagues, he has further enriched his research endeavors, paving the way for groundbreaking pharmaceutical breakthroughs. Nghe Nguyen-Ba's remarkable contributions will undoubtedly inspire future innovators in their quest to improve global health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile